SS 19 - Palliative Care 1: Palliative Radiotherapy from SABR to EBRT: Improving QOL, Prognostication, and Toxicities

Presentations

• 10:45am - 12:00pm PT

  Palliative Care 1: Palliative radiotherapy from SABR to EBRT: Improving QOL, prognostication, and toxicities

  Speaker: Melisa Boersma, MD - University of Kansas Cancer Center, Kansas City
• 10:45am - 10:55am PT

  Treatment with Stereotactic Ablative Radiotherapy for up to Five Oligometastases in Patients with Cancer: Long-Term Outcomes of the Nonrandomized Phase 2 SABR-5 Clinical Trial

  Speaker: Curtis Leclerc, MS - University of British Columbia, Vancouver
• 10:55am - 11:05am PT

  Predictors of Skeletal-Related Events and Quality of Life Dimensions among Patients with High-Risk, Asymptomatic Bone Metastases with or without Early Radiation Therapy: Secondary Analysis of a Multicenter, Randomized Phase II Clinical Trial

  Speaker: Kaitlyn Lapen, MD - Memorial Sloan Kettering Cancer Center, New York
• 11:05am - 11:15am PT

  The Effectiveness of QUAD Shot Regimen for Advanced Head and Neck Squamous Cell Carcinoma: A Multicenter Prospective Observational Study (JROSG 18-2)

  Speaker: Ryo Toya, MD, PhD - Nagasaki University, Nagasaki
• 11:15am - 11:25am PT

  Impact of Palliative Radiation on Lymphopenia and Survival in Cancer Patients

  Speaker: Joshua Kim, BS - Zucker School of Medicine at Hofstra/Northwell, New Hyde Park
• 11:25am - 11:35am PT

  Prognostic Nutritional Index as a Prognostic Factor in Stage IV Lung Cancer Patients Receiving Palliative Radiation Therapy

  Speaker: Hidekazu Tanaka, MD, PhD - Yamaguchi University Graduate School of Medicine, Ube
• 11:35am - 11:45am PT

  Discussant

  Speaker: Zachary Kohutek, MD, PhD - Vanderbilt University Medical Center, Nashville